Science Explorer Interactive view Map
Company · West Chester · United States

Molecular Targeting Technologies (United States)

mtarget.comROR OpenAlex
Research works
39
▼ 65% vs 2013–17
Citations
652
16.6 per fractional work
Top-10% rate
16.5%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Molecular Targeting Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Molecular Targeting Technologies (United States)?

Ranked on the composite score, Koon Y. Pak and Brian D. Gray lead among researchers whose main affiliation is Molecular Targeting Technologies (United States).

  1. 1 Koon Y. Pak United States · #923,290 worldwide 24 citations · 16 works
  2. 2 Brian D. Gray United States · #1,587,137 worldwide 15 citations · 19 works
All ranked researchers at Molecular Targeting Technologies (United States)

Which keywords describe research at Molecular Targeting Technologies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: PET Imaging, Reactive Oxygen Species, Tumor Targeting, Targeted Therapy, Cancer Treatment, Dosimetry, Radioimmunotherapy and Radiopharmaceuticals.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. PET Imaging5▲ 62×2 topics
  2. Reactive Oxygen Species5▲ 25×6 topics
  3. Tumor Targeting5▲ 91×3 topics
  4. Targeted Therapy4▲ 53×3 topics
  5. Cancer Treatment4▲ 44×3 topics
  6. Dosimetry4▲ 116×2 topics
  7. Radioimmunotherapy4▲ 265×1 topic
  8. Radiopharmaceuticals4▲ 265×1 topic
  9. Cancer4▲ 7.2×10 topics
  10. Immunotherapy4▲ 15×6 topics
  11. Cancer Therapy4▲ 15×3 topics
  12. Nanoparticles4▲ 7.2×3 topics
  13. Inflammation3▲ 3.1×13 topics
  14. Photodynamic Therapy3▲ 43×3 topics
  15. Gene Therapy2▲ 22×3 topics
  16. Fluorescence Imaging2▲ 51×1 topic
  17. Photothermal Therapy2▲ 67×1 topic
  18. Quantitative2▲ 46×2 topics
  19. Imaging2▲ 15×2 topics
  20. Macrophages2▲ 31×2 topics
  21. Apoptosis2▲ 13×4 topics
  22. Biomedical Applications2▲ 4.5×5 topics
  23. Angiogenesis2▲ 11×3 topics
  24. PET/CT2▲ 60×1 topic
  25. tumor2▲ 60×1 topic
  26. Pathogenesis2▲ 7.8×5 topics
  27. Tumor Microenvironment2▲ 12×2 topics
  28. Cancer Immunotherapy2▲ 28×2 topics
  29. CD472▲ 254×1 topic
  30. apoptotic cells2▲ 254×1 topic
  31. Bcl-2 Family1▲ 126×1 topic
  32. Cell Death1▲ 18×1 topic
  33. Drug Delivery1▲ 7.5×4 topics
  34. Gene Expression1▲ 5.9×6 topics
  35. Myocardial Infarction1▲ 13×4 topics
  36. Arginine Deprivation1▲ 72×1 topic
  37. Bacterial Therapy1▲ 72×1 topic
  38. Nanocarriers1▲ 72×1 topic
  39. Transmission1▲ 60×2 topics
  40. Virus1▲ 26×2 topics

Which research topics does Molecular Targeting Technologies (United States) publish most on?

By volume in 2022–2025: Nanoplatforms for cancer theranostics, Lung Cancer Research Studies, Radiopharmaceutical Chemistry and Applications and Cancer Research and Treatments.

Nanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksRadiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksMedical Imaging Techniqu…0Medical Imaging Techniques and Applications: 0 fractional worksNeuroendocrine Tumor Res…0Neuroendocrine Tumor Research Advances: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksOrthopedic Infections and Treatments: 0 fractional worksBlood Coagulation and Thrombosis Mechanisms: 0 fractional worksPhagocytosis and Immune Regulation: 0 fractional works
Biomedical EngineeringOncologyRadiology, Nuclear Medicine and ImagingBiotechnology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  2. 2 Lung Cancer Research Studies Oncology 0 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Cancer Research and Treatments Biotechnology 0 works
  5. 5 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Orthopedic Infections and Treatments Surgery 0 works
  9. 9 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
  10. 10 Phagocytosis and Immune Regulation Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.3%not open63.7%

World: 28% of research is openly available.

with international co-authors21.9%domestic only78.1%

World: 19% is written across borders.

How has Molecular Targeting Technologies (United States)'s research output changed?

Output in 2018–2022 was 65% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in West Chester

All research institutions in West Chester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.